The role of nitric oxide in pediatric patients with portal hypertension

Journal of Tropical Pediatrics

Volumn 49, Issue 1, 2003, Pages 33-36

  Shams, Vida ^a   Erkan, Tülay ^a   Gümüştaş, Mustafa K ^a   Çullu, Fügen ^a   Kutlu, Tufan ^a   Kaya, Hafize ^a   Aydin, Seval ^a   Tümay, Güngör ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; PATHOGENESIS; PORTAL HYPERTENSION; VASODILATATION;

ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHILD; COLORIMETRY; FEMALE; FIBROSIS; HUMANS; HYPERTENSION, PORTAL; MALE; NITRIC OXIDE;

EID: 0037325873     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/49.1.33     Document Type: Article

References (25)

1. Cahill PA, Sitzman JV. Nitric oxide and portal hypertension. J Hepatol 1995; 23: 355-56.
2. Kanwar S, Kubes P, Tepperman BL, Lee SS. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J Hepatol 1996; 25: 85-9.
3. Lee F, Colmbato L, Albillos A, Groszmann RJ. N-Nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17: 84-90.
4. Talavera JCL, Cadelina G, Olchowski J. Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portalhypertensive rats. Hepatology 1996; 23: 1616-21.
5. Ginès P, Fernández-Esparrach G, Arroyo V, Rodés J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997; 17: 175-89.
6. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988: 8: 1151-57.
7. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol 1995; 23: 218-24.
8. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-46.
9. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
10. Laffi G, Foschi M, Masini E, et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22: 1666-73.
11. Whittle BJR, Moncada S. NO: the elusive mediator of hyperdynamic circulation of cirrhosis? Hepatology 1992; 16: 1089-92.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993: 329: 2002-12.
13. Stark M, Sarr MG. Nitric oxide mediates inhibitory nerve input in human and canine jejunum. Gastroenterology 1993; 104: 398-409.
14. Mourelle M, Guarner F, Moncada S, Malagelada JR. The arginine/nitric oxide pathway modulates sphincter of oddi motor activity in guinea pigs and rabbits. Gastroenterology 1993; 105: 1299-305.
15. Salzman AL. Nitric oxide in the gut. New Horiz 1995; 3: 33-49.
16. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 1993; 212: 359-65.
17. Fernandez M, Garcia-Pagan JC, Casadevall M, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995; 108: 1487-95.
18. Battista S, Bar F, Mengozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997; 26: 75-80.
19. Matsumato A, Ogura K, Hirata Y, et al. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern Med 1995; 123: 110-13.
20. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991: 181: 852-57.
21. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-78.
22. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994: 28: 34-9.
23. Forrest EH, Jones AL, Dillon JF, Walker J, Hayes PC. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol 1995; 23: 254-58.
24. Hartleb M, Michielsen PP, Dziurkowska-Marek A. The role of nitric oxide in portal hypertensive systemic and portal vascular pathology. Acta Gastroenterol Belg 1997; 60: 222-32.
25. Chu CJ, Lee FY, Wang SS, et al. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension. J Hepatol 1999; 30: 1105-11.